Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW)
NCT ID: NCT04595175
Last Updated: 2020-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2020-06-10
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment
NCT04542200
Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination
NCT05977192
The SINCERE Intervention to Address COVID-19 Health Disparities
NCT05228886
Assessment of SARS-CoV-2 Seroprevalence in Detention
NCT04516512
COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement
NCT05582746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Be an active member of the CommonSpirit Health workforce or medical staff during the COVID-19 pandemic and at the time of enrollment; and
3. Have access to the Internet; and
4. The ability to provide informed consent.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chandler Regional Medical Center
UNKNOWN
Arizona General Hospital
UNKNOWN
Mercy Gilbert Medical Center
UNKNOWN
Brian Tiffany, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brian Tiffany, MD
Chief Medical Officer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian Tiffany, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Chief Medical Officer Dignity Health Arizona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chandler Regional Medical Center
Chandler, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
COVID-19 Death toll
Healthcare worker COVID-19 infection rates
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-510-157-66-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.